These sEVs are internalized by HCC cells to downregulate androgen receptor (AR) expression, activating the AR/PHLPP/p-AKT/β-catenin signaling axis and promoting tumor progression. This evidence concerns the gene AKT1 and hepatocellular carcinoma.